Trastuzumab Unknown Status Phase 3 Trials for Cancer, Breast Diagnostic

IndicationsStatusPurposePhase
Unknown StatusDiagnostic3
clinicaltrials.gov IdentifierTitleDrugs
NCT01917578Study of Breast Cancer Shrinkage Modes After Neoadjuvant Chemotherapy With Whole-mount Serial Sections and Three-dimensional Pathological and MRI Reconstruction